EE538 Impact of Nirsevimab on the Health Burden and Costs of Respiratory Syncytial Virus (RSV) in the Infant Population From the Healthcare System in Argentina
Abstract
Authors
Leandro Javier Pastori Constanza Silvestrini Viola Ariel Bardach Néstor Vain Natalia Espinola